| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.10. | QLife Holding AB: The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended | 59 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd. ("Hipro"). The... ► Artikel lesen | |
| 22.09. | Qlife Holding AB announces the outcome of the exercise of warrants series TO 6 | 1 | Cision News | ||
| 15.09. | QLife Holding AB: Qlife announces additional product line and progresses two new tests into clinical trials | 110 | GlobeNewswire (Europe) | Qlife, a first mover in clinical-grade home diagnostics, and its partner Hipro Biotechnology are advancing two additional biomarker tests-nt-proBNP and potassium-into clinical trials targeting Congestive... ► Artikel lesen | |
| 27.08. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April to June 2025 | 140 | GlobeNewswire (Europe) | Towards a merger with a vision
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second quarter 2025
Revenue... ► Artikel lesen | |
| QLIFE Aktie jetzt für 0€ handeln | |||||
| 27.08. | QLife Holding AB: Progress update on the reverse takeover process between Qlife and Hipro | 131 | GlobeNewswire (Europe) | Gothenburg, Sweden - Qlife Holding AB ("Qlife" or the "Company") and Hipro Biotechnology Co., Ltd. ("Hipro") remain fully committed to completing the transaction announced in the Letter of Intent signed... ► Artikel lesen | |
| 21.08. | Qlife Holding AB increases existing credit facility and extends the maturity date | 1 | Cision News | ||
| 21.08. | QLIFE HOLDING AB: Qlife together with Birmingham Women's and Children's NHS Foundation Trust achieve positive results for its rare disease self-test PHE product | 2 | Cision News | ||
| 09.07. | QLIFE HOLDING AB: Qlife resolves to carry out a directed set-off issue of approximately SEK 2.47 million in accordance with previously announced credit facility agreement | 1 | Cision News | ||
| 05.06. | Qlife Holding AB receives observation status | 225 | GlobeNewswire | Today, June 5, 2025, Qlife Holding AB (the "Company") issued a press release with information that it has entered into a letter of intent for a reverse takeover of Hipro Biotechnology Co., Ltd.,... ► Artikel lesen | |
| 05.06. | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 216 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | |
| 28.05. | QLife Holding AB: Bulletin from the annual general meeting 2025 of Qlife Holding AB | 138 | GlobeNewswire (Europe) | Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
| 20.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2025 | 268 | GlobeNewswire (Europe) | Progress on all levels
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2025
Revenue in the... ► Artikel lesen | |
| 25.03. | QLife Holding AB: Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | 203 | GlobeNewswire (Europe) | The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Notified... ► Artikel lesen | |
| 21.03. | QLife Holding AB: Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | 258 | GlobeNewswire (Europe) | Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below.
Election and remuneration of the board of directors
The... ► Artikel lesen | |
| 04.03. | The observation status for Qlife Holding AB is removed | 210 | GlobeNewswire | On February 13, 2024, Qlife Holding AB (the "Company") was given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On February 26... ► Artikel lesen | |
| 26.02. | QLife Holding AB: Qlife announces outcome in rights issue | 295 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 17.02. | QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform | 367 | GlobeNewswire (Europe) | Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results... ► Artikel lesen | |
| 06.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October to December 2024 | 243 | GlobeNewswire (Europe) | Transition to a commercial business
Financial summary - fourth quarter 2024
Revenue in the period amounted to kSEK 50 (30).
EBITDA for the period amounted to kSEK -7,721 (-86,903), and net loss... ► Artikel lesen | |
| 05.02. | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.02.2025 | 268 | Xetra Newsboard | Das Instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY wird cum Kapitalmassnahme gehandelt am 05.02.2025 und ex Kapitalmassnahme am 06.02.2025 The instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY is traded... ► Artikel lesen | |
| 31.01. | QLife Holding AB: Qlife comments on the CEO of the company getting a sanction from Finansinspektionen | 198 | GlobeNewswire (Europe) | The CEO of Qlife Thomas Warthoe has been sanctioned by Finansinspektionen related to insider information.
The sanction relates to an incident in February 2023 when Thomas Warthoe forwarded an email... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MOUNTAIN VALLEY MD | 0,007 | -36,36 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| SIEMENS HEALTHINEERS | 45,000 | -8,63 % | 30 Prozent-Rallye voraus?: Hier ist Siemens Healthineers Weltspitze! Analysten sehen großen Kurssprung | © Foto: Daniel Karmann/dpa Der November könnte für Siemens Healthineers einige wichtige Weichenstellungen bedeuten. Auch die Aktie könnte dann endlich wieder Fahrt aufnehmen, meinen die Analysten der... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,760 | +1,43 % | Trotz Gewinn-Überraschung: FMC rutscht nach den Zahlen ans DAX-Ende - Großaktionär vor Aktienverkauf? | © Foto: picture alliance / dpaFresenius Medical Care hat im dritten Quartal 2025 deutlich besser abgeschnitten als erwartet. Dennoch bricht die Aktie am Dienstag deutlich ein. Grund sind Spekulationen... ► Artikel lesen | |
| FRESENIUS | 48,050 | -0,97 % | Fresenius hebt EBIT-Prognose an - Starkes Quartal bei Kabi und solide Entwicklung bei Helios | Der Gesundheitskonzern Fresenius hat nach einem kräftigen Gewinnanstieg im dritten Quartal seine Prognose für das Gesamtjahr 2025 angehoben. Das Unternehmen rechnet nun mit einem währungsbereinigten... ► Artikel lesen | |
| GERRESHEIMER | 25,480 | -1,92 % | Aixtron, Gerresheimer, Hypoport, Nordex, Puma, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,600 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,800 | -0,23 % | Carl Zeiss Meditec-Aktie entfacht neue Spekulationen - was hinter den Kulissen passiert, bleibt nicht unbemerkt! | ||
| HIMS & HERS HEALTH | 38,170 | +0,18 % | Zahlen veröffentlicht: Hims & Hers übertrifft Umsatzprognosen: Kommt ein Deal mit Novo Nordisk? | © Foto: Dall-EHims & Hers Health setzt auf Expansion, Diagnostik und einen möglichen Deal mit dem dänischen Pharmariesen Novo Nordisk. Die Aktie steigt nachbörslich deutlich.Das US-amerikanische Telemedizinunternehmen... ► Artikel lesen | |
| UNITEDHEALTH | 285,60 | +0,11 % | UnitedHealth wieder auf dem absteigenden Ast - Cigna crasht nach Warnung | Der US-Krankenversicherungsmarkt bleibt in einem sehr schwierigen Fahrwasser - darüber hinweg kann auch die leicht angehobene Gewinnprognose von UnitedHealth in dieser Woche nicht täuschen. Mit Cigna... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 32,670 | +2,00 % | BrightSpring Health Services GAAP EPS of $0.17 misses by $0.15, revenue of $3.33B misses by $20M | ||
| ECKERT & ZIEGLER | 16,070 | -2,07 % | Eckert & Ziegler-Aktie sorgt für Schockwellen - Investoren verlieren das Vertrauen! | ||
| GENEDX | 137,16 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,055 | -0,20 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| NUTEX HEALTH | 131,32 | +3,68 % | Nutex Health, Inc.: Nutex Health Provides Corporate Update | Significant Year-over-Year Growth in Patient Volume and Cash Collections
HOUSTON, Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")... ► Artikel lesen | |
| PROGYNY | 18,890 | +1,78 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen |